Pick's disease and frontotemporal dementias: Emerging clinical and molecular concepts

Neurologist

Volumn 5, Issue 4, 1999, Pages 205-212

  Miller, Bruce L ^a,c   Boone, Kyle ^b   Geschwind, Dan ^b   Wilhelmsen, Kirk ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Behavior; Frontotemporal dementia; Genetic; Pick's disease; Tau

Indexed keywords

ANTIDEPRESSANT AGENT; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DEGENERATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; PARKINSONISM; PICK PRESENILE DEMENTIA; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM;

EID: 0032797926     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-199907000-00004     Document Type: Review

References (73)

1. Cummings JL, Benson DF. Dementia: A clinical approach. Boston: Butterworth, 1992.
2. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987;6:193-208.
3. Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration. New York: Churchill-Livingstone, 1996.
4. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5.
5. Clark LN, Poorkaj P, Wszolek Geschwind DN, Nasreddine ZS, Miller BL, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related chromosome 17-linked neurodegenerative disorders. Proc Natl Acad Sci U S A 1998; 95:13103-7.
6. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 1998;95:7737-41.
7. Berrios GE. The history of mental symptoms: Descriptive psychopathology since the nineteenth century. Cambridge: Cambridge University Press, 1996.
8. Gustafson L, Brun A, Risberg J. Frontal lobe degeneration of non-Alzheimer type. H. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-23.
9. Neary D, Snowden JS, Shields RA. Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-9.
10. Neary D, Snowden JS, Bowen DM, Sims NR, Mann DMA, Benton JS, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 1986;49:163-74.
11. Brun A, Englund B, Gustafson L, Passant U, Mann DMA, Neary D, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-8.
12. Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993;4:143-8.
13. Knopman DS, Mastri AR, Frey WH, SungJH, Ruston T. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia. Neurology 1990;40:251-6.
14. Miller BL, Cummings JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, et al. Frontal lobe degeneration: Clinical, neuropsychological and SPECT characteristics. Neurology 1991;41:1374-82.
15. Petersen RB, Tabaton M, Chen SG, Monari L, Richardson SL, Manetto V, et al. Familial progressive subcortical gliosis: presence of prions and linkage to chromosome 17. Neurology 1995;45:1062-7.
16. Caselli RJ, Windebank AJ, Petersen RC, Komori R, Parisi JE, Okazake H, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 1993;33:200-7.
17. Kertesz A, Hudson L, Mackenzie IRA, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44: 2065-72.
18. Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996;40:893-9.
19. Frisoni GB, Beltramello A, Geroldi C, Weiss C. Bianchetti A, Trabucchi M. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry 1996;61:157-65.
20. Stevens M, van Duijn CM, Kamphorst W, de Knijff P, Heutink P, van Gool WA, et al. Familial aggregation in frontotemporal dementia. Neurology 1988;50:1541-5.
21. Hodges JR, Patterson K. Nonfluent progressive aphasia and semantic dementia: A comparative neuropsychological study. J Int Neuropsychol Soc 1996;6:511-24.
22. Mitsuyama Y. Presenile dementia with motor neuron disease. Dementia 1993;4:137-12.
23. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592-8.
24. Morris JC, Cole M, Banker BQ, Wright D. Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 1984;16:455-66.
25. Warrington EK. The selective impairment of semantic memory. Q J Exp Psychol 1976;4:635-57.
26. Hodges JR, Patterson K, Oxbury S, Funnell F. Semantic dementia: Progressive fluent aphasia with temporal lobe atrophy. Brain 1992; 115:1783-1806.
27. Snowden JS, Neary D, Mann DMA, Goulding PJ, Testa HJ. Progressive language disorder due to lobar atrophy. Ann Neurol 1992; 31:174-83.
28. Miller BL, Chang L, Mena I, Boone KB, Lesser I. Progressive right frontotemporal degeneration: Clinical, neuropsychological and SPECT characteristics. Dementia 1993;4:204-13.
29. Neary D. Frontotemporal degeneration, Pick disease, and corticobasal degeneration. One entity or 3? 3. Arch Neurol 1997;54:1425-7.
30. Nasreddine Z, Loginov M, Clark L, Laramche J, Miller B, Lamontagne A, et al. From genotype to phenotype: A clinical, pathological and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 1999;45:704-15.
31. Chow T, Miller BL, Hayashi V, Geschwind D. Familial studies of frontotemporal dementia. Arch Neurol. In press.
32. Zhou L, Miller BL, McDaniel CH, Kelly L, Kim OJ, Miller CA. Fronto-temporal dementia: Neuropil spheroids contain modified tau. Ann Neurol 1998;44:99-109.
33. Mendez MF, Selwood A, Mastri AR, Frey WH. Pick's disease versus Alzheimer's disease: A comparison of clinical characteristics. Neurology 1993;43:289-92.
34. Wilhelmsen K, Lynch T, Pavlou E, Nygaard TG. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Human Genet 1994;55:1150-65.
35. Foster NL, Wilhelmsen KC, Sima AAF, Jones MZ, D'Amato C, Gilman S, et al. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A consensus statement. Ann Neurol 1997;41:706-15.
36. Wilhelmsen K. Frontotemporal dementia is on the MAPtau. Ann Neurol 1997;41:139-40.
37. Sima AAF, Defendini R, Keohane C, D'Amato C, Foster NL, Parchi P, et al. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996;39:734-43.
38. Ghetti B, Murrell J, Farlow MR, Crowther RA, Goedert M, Spillantini MG. Molecular neuropathology of a multiple system tauopathy: a chromosome 17 linked presenile dementia. Neurology 1997; 48:A356.
39. Reed LA, Schmidt ML, Wszolek ZK, Balin BJ, Soontornniyomkij V, Lee VMY, et al. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("Pallido-Ponto-Nigral-Degeneration"). J Neuropathol Exp Neurol 1998;57:588-601.
40. Poorkaj P, Bird T, Wijsman E, Nemens E, Garruto RM, Anderson L, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43:815-25.
41. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-26.
42. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996;383;550-3.
43. Geschwind D, Karrim J, Koras N, Nelson SF, Miller BL. The Apo E4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 1998;44:134-8.
44. Kosik KS. Tau protein and neurodegeneration. Mol Neurobiol 1990; 4:171-9.
45. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987;235:885-90.
46. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991;353:844-6.
47. Goate AM, Chartier Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6.
48. Levy M, Miller BL, Cummings JL, Fairbanks LA, Craig A. Alzheimer's disease and frontotemporal dementia: Behavioral distinctions. Arch Neurol 1996;53:687-90.
49. Miller BL, Ikonte C, Ponton MP, Levy M, Boone K, Darby A, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia. Neurology 1997;48:937-42.
50. RisbergJ, Passant U, Warkentin S, Warkentin S, Gustafson L. Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type. Dementia 1993;4:186-7.
51. Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A. SPECT in dementia: Clinical and pathological correlation. J Am Geriatr Soc 1995;43:1243-7.
52. Edwards-Lee T, Miller BL, Benson DF, Cummings JL, Russell G, Mena I. The temporal lobe variant of frontotemporal dementia. Brain 1997;120:1027-40.
53. Waltz J, Knowlton B, Holyoak K, Boone KB, Mishkin FS, de Menezes Santos M, et al. A system for relational reasoning in human prefrontal cortex. Psychol Sci. 1999;10:119-25.
54. Miller DL, Cummings JL, Boone K, Prince F, Ponton M, Cotman C. Emergence of artistic talent in frontotemporal dementia. Neurology 1998;51:978-81.
55. Sparks DL, Markesbery WR: Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol 1991;48:796-9.
56. Miller BL, Darby AL, Swartz JR, Yener GG, Mena I. Dietary changes, compulsions and sexual behavior in fronto-temporal degeneration. Dementia 1995;6:195-9.
57. Swartz R, Miller BL, Darby A, Schuman S. Frontotemporal dementia: Treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997;58:212-6.
58. Jagust WJ, Reed BR, Scab JP, Kramer JH, Budinger TJ. Clinicalphysiologic correlates of Alzheimer's disease and frontal lobe dementia. Am J Physiol Imaging 1989;4:89-96.
59. Johanson A, Hagberg B. Psychometric characteristics in patients with frontal lobe degeneration of non-Alzheimer type. Arch Gerontol Geriatr 1989;8:129-37.
60. Mendez M, Cherrier M, Perryman KM, Pachana N, Miller BL, Cummings JL. Frontotemporal dementia versus Alzheimer disease: Differential cognitive features. Neurology 1996;47:1189-93.
61. Pachana N, Boone KB, Miller BL, Cummings JL. Comparison of neuropsychological functioning in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc 1996;2:505-10.
62. Gregory CA, Orrell M, Sahakian B, Hodges JR. Can frontotemporal dementia and Alzheimer's disease be differentiated using a brief battery of tests? Int J Geriatr Psychiatry 1997;3:375-83.
63. Boone K, Miller BL, Lee A. Cognitive profiles in right versus left frontotemporal dementia. [abstract]. J Int Neuropsychol Soc 1998;4: 62.
64. Kertesz A. Frontotemporal degeneration, Pick disease, and corticobasal degeneration. One entity of 3? 1. Arch Neurol 1997 54:1427-9
65. Mon H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: A disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol (Berl) 1994;88:113-21.
66. Yamashita M, Yamamoto T, Senzaki H. An autopsy case of corticobasal degeneration with predominant involvement of the prefrontal lobe, limbic system, and especially of medial temporal base. No To Shinkei 1998;50:463-8.
67. Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 1998;8:403-406.
68. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol (Berl) 1996;91:127-34.
69. Steele JC, Richardson JC, Olszewski R. Progressive supranuclear palsy: A heterogeneous degeneration involving the brain stem, basal ganglia, and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;1964;10333-54.
70. Johnson KA, Sperling RA, Holman BL, Nagel JS, Growdon JH. Cerebral perfusion in progressive supranuclear palsy. J Nucl Med 1992; 33:704-9.
71. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996;40:139-48.
72. Andreadis CC, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997;41:277-81.
73. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: Clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 1984;47:953-9.